Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States.
- DOI
- 10.1186/s12981-024-00668-7
- Published
- 2024 Oct 26
- Container
- AIDS research and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12981-024-00668-7,
title = {Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States.},
author = {Pierone G and Fusco JS and Brunet L and Vannappagari V and Sarkar S and Henegar CE and van Wyk J and Wohlfeiler MB and Mills A and Fusco GP},
year = {2024},
journal = {AIDS research and therapy},
doi = {10.1186/s12981-024-00668-7},
url = {https://doi.org/10.1186/s12981-024-00668-7}
}RIS
TY - JOUR TI - Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States. AU - Pierone G AU - Fusco JS AU - Brunet L AU - Vannappagari V AU - Sarkar S AU - Henegar CE AU - van Wyk J AU - Wohlfeiler MB AU - Mills A AU - Fusco GP PY - 2024 JO - AIDS research and therapy DO - 10.1186/s12981-024-00668-7 UR - https://doi.org/10.1186/s12981-024-00668-7 ER -
APA
G, P., JS, F., L, B., V, V., S, S., CE, H., J, V. W., MB, W., A, M., & GP, F. (2024). Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States.. AIDS research and therapy. https://doi.org/10.1186/s12981-024-00668-7
Source records
- pubmed · retrieved 2026-09-26T12:29:03.288Z